Lynn McLaughlin's Blog, page 10

May 27, 2019

May 3, 2019

Much appreciation to Marlene Markham-Gay for the article in the May edition of Biz X Magazine.

My family and I are honoured to have been recognized. In addition to the locations provided in her review, the book is also now available at the Essex Railway Station. For audiobook, paperback (for order) or Ebook editions, all of the links are on this webpage. http://www.steeringthroughit.com





“…this is a book everyone can learn from. It is also a testimony to the bravery and courage individuals must have to overcome or accept the affects of a life-threatening illness, whether that could be temporary or lasting” pg. 52




https://bizxmagazine.com/biz-x-magazine-may-2019-vol-22-issue-5/?fbclid=IwAR25FnPohg8Er_uaZu-UMsCSEKLPXwlpLnFMp8FpXvjaRpXqr6rZYVFSmgA

The post Much appreciation to Marlene Markham-Gay for the article in the May edition of Biz X Magazine. appeared first on Steering Through It.

 •  0 comments  •  flag
Share on Twitter
Published on May 03, 2019 07:49

April 28, 2019

April 16, 2019

April 10, 2019

April 1, 2019

March 25, 2019

“The internationally accepted, standard treatment regimen for the most common type of brain cancer is not fully accessible in parts of Canada. This contradicts the approach of most other developed countries that have universal health care systems.” People

The Brain Tumour Foundation of Canada has posted detailed information on its website (see link below).   Temozolomide is produced in both brand and generic form and has been long approved for funding on provincial formularies. The issue is not its funding, but in HOW that funding is accessed.


The hope is that this roadmap may serve as a resource to those shaping a national system of pharmacare to demonstrate why a consistent, standardized and monitored method of drug access is essential to maintaining standard of care for cancer in Canada. 


Currently, in Canada, Temozolomide is funded in one of three ways:

The province takes responsibility for funding (100%)
Technically it’s the responsibility of the patient to pay, but the province or hospital offers alternative funding
It is considered a prescription and is a patient’s responsibility to pay.

This means that if you live anywhere in Canada other than British Columbia, Alberta or Saskatchewan, you have some or all of the responsibility as the patient to pay (see roadmap for details).  Imagine, receiving a diagnosis of brain cancer, and having to find a way to pay for the chemotherapy that is the standard treatment.
 ps://www.braintumour.ca/13431/tmz-map

The post “The internationally accepted, standard treatment regimen for the most common type of brain cancer is not fully accessible in parts of Canada. This contradicts the approach of most other developed countries that have universal health care systems.” People with brain cancer should not have to pay for their chemotherapy, regardless of where they reside in this country! appeared first on Steering Through It.

 •  0 comments  •  flag
Share on Twitter
Published on March 25, 2019 07:06

March 12, 2019

The International Women’s Day Writers of the World Discussion Panel

https://www.youtube.com/embed/ehg1ItMrR1w?rel=0


A privilege and an honour to join these strong, inspiring women: Rebecca Rodarte, Debra Falasco and  Cristine Ristaino, as we share our tips for how to face life’s greatest challenges.  Please share!


 


 


The post The International Women’s Day Writers of the World Discussion Panel appeared first on Steering Through It.

 •  0 comments  •  flag
Share on Twitter
Published on March 12, 2019 17:34

March 11, 2019